Lauren DAngelo
Chief Operating Officer presso ALPHA COGNITION INC.
Profilo
Lauren DAngelo is currently the Chief Operating Officer at Alpha Cognition, Inc. She previously worked as the Vice President-Marketing & Commercial Strategy at Urovant Sciences, Inc. Ms. DAngelo completed her undergraduate degree at Florida State University and holds an MBA from the University of Florida.
Posizioni attive di Lauren DAngelo
| Società | Posizione | Inizio |
|---|---|---|
| ALPHA COGNITION INC. | Chief Operating Officer | 01/01/2023 |
Precedenti posizioni note di Lauren DAngelo
| Società | Posizione | Fine |
|---|---|---|
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Sales & Marketing | - |
Formazione di Lauren DAngelo
| Florida State University | Undergraduate Degree |
| University of Florida | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ALPHA COGNITION INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Health Technology |
- Borsa valori
- Insiders
- Lauren DAngelo
